Literature DB >> 17671187

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.

Minati Satpathy1, Liyun Cao, Roxana Pincheira, Robert Emerson, Robert Bigsby, Harikrishna Nakshatri, Daniela Matei.   

Abstract

Tissue transglutaminase (TG2) is involved in Ca(2+)-dependent aggregation and polymerization of proteins. We previously reported that TG2 mRNA is up-regulated in epithelial ovarian cancer (EOC) cells compared with normal ovarian epithelium. Here, we show overexpression of the TG2 protein in ovarian cancer cells and tumors and its secretion in ascites fluid and define its role in EOC. By stable knockdown and overexpression, we show that TG2 enhances EOC cell adhesion to fibronectin and directional cell migration. This phenotype is preserved in vivo, where the pattern of tumor dissemination in the peritoneal space is dependent on TG2 expression levels. TG2 knockdown diminishes dissemination of tumors on the peritoneal surface and mesentery in an i.p. ovarian xenograft model. This phenotype is associated with deficient beta(1) integrin-fibronectin interaction, leading to weaker anchorage of cancer cells to the peritoneal matrix. Highly expressed in ovarian tumors, TG2 facilitates i.p. tumor dissemination by enhancing cell adhesion to the extracellular matrix and modulating beta(1) integrin subunit expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671187     DOI: 10.1158/0008-5472.CAN-07-0307

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  Dependence of invadopodia function on collagen fiber spacing and cross-linking: computational modeling and experimental evidence.

Authors:  Heiko Enderling; Nelson R Alexander; Emily S Clark; Kevin M Branch; Lourdes Estrada; Cornelia Crooke; Jérôme Jourquin; Nichole Lobdell; Muhammad H Zaman; Scott A Guelcher; Alexander R A Anderson; Alissa M Weaver
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

2.  A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival.

Authors:  Lindsey K Boroughs; Marc A Antonyak; Richard A Cerione
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

3.  Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression.

Authors:  Jiyoon Lee; Salvatore Condello; Bakhtiyor Yakubov; Robert Emerson; Andrea Caperell-Grant; Kiyotaka Hitomi; Jingwu Xie; Daniela Matei
Journal:  Clin Cancer Res       Date:  2015-06-03       Impact factor: 12.531

Review 4.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

5.  The transglutaminase 2 gene is aberrantly hypermethylated in glioma.

Authors:  Lisa M Dyer; Kevin P Schooler; Lingbao Ai; Corinne Klop; Jingxin Qiu; Keith D Robertson; Kevin D Brown
Journal:  J Neurooncol       Date:  2010-07-03       Impact factor: 4.130

Review 6.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

7.  Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.

Authors:  Salvatore Condello; Livia Sima; Cristina Ivan; Horacio Cardenas; Gary Schiltz; Rama K Mishra; Daniela Matei
Journal:  Cancer Res       Date:  2018-03-06       Impact factor: 12.701

8.  Tissue transglutaminase-1 promotes stemness and chemoresistance in gastric cancer cells by regulating Wnt/β-catenin signaling.

Authors:  Haitao Huang; Zhiqi Chen; Xiuqin Ni
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

9.  Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.

Authors:  Liyun Cao; Daniela N Petrusca; Minati Satpathy; Harikrishna Nakshatri; Irina Petrache; Daniela Matei
Journal:  Carcinogenesis       Date:  2008-07-29       Impact factor: 4.944

Review 10.  Transglutaminase is a tumor cell and cancer stem cell survival factor.

Authors:  Richard L Eckert; Matthew L Fisher; Dan Grun; Gautam Adhikary; Wen Xu; Candace Kerr
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.